These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

1117 related items for PubMed ID: 26487287

  • 1. New global analysis of the microRNA transcriptome of primary tumors and lymph node metastases of papillary thyroid cancer.
    Saiselet M, Gacquer D, Spinette A, Craciun L, Decaussin-Petrucci M, Andry G, Detours V, Maenhaut C.
    BMC Genomics; 2015 Oct 21; 16():828. PubMed ID: 26487287
    [Abstract] [Full Text] [Related]

  • 2. Association of BRAF V600E Mutation and MicroRNA Expression with Central Lymph Node Metastases in Papillary Thyroid Cancer: A Prospective Study from Four Endocrine Surgery Centers.
    Han PA, Kim HS, Cho S, Fazeli R, Najafian A, Khawaja H, McAlexander M, Dy B, Sorensen M, Aronova A, Sebo TJ, Giordano TJ, Fahey TJ, Thompson GB, Gauger PG, Somervell H, Bishop JA, Eshleman JR, Schneider EB, Witwer KW, Umbricht CB, Zeiger MA.
    Thyroid; 2016 Apr 21; 26(4):532-42. PubMed ID: 26950846
    [Abstract] [Full Text] [Related]

  • 3. Expression profile and clinical significance of microRNAs in papillary thyroid carcinoma.
    Peng Y, Li C, Luo DC, Ding JW, Zhang W, Pan G.
    Molecules; 2014 Aug 05; 19(8):11586-99. PubMed ID: 25100252
    [Abstract] [Full Text] [Related]

  • 4. MicroRNA-based molecular classification of papillary thyroid carcinoma.
    Rosignolo F, Memeo L, Monzani F, Colarossi C, Pecce V, Verrienti A, Durante C, Grani G, Lamartina L, Forte S, Martinetti D, Giuffrida D, Russo D, Basolo F, Filetti S, Sponziello M.
    Int J Oncol; 2017 May 05; 50(5):1767-1777. PubMed ID: 28393181
    [Abstract] [Full Text] [Related]

  • 5. Integrated Characterization of MicroRNA and mRNA Transcriptome in Papillary Thyroid Carcinoma.
    Mohamad Yusof A, Jamal R, Muhammad R, Abdullah Suhaimi SN, Mohamed Rose I, Saidin S, Ab Mutalib NS.
    Front Endocrinol (Lausanne); 2018 May 05; 9():158. PubMed ID: 29713312
    [Abstract] [Full Text] [Related]

  • 6. In-depth characterization of the microRNA transcriptome in normal thyroid and papillary thyroid carcinoma.
    Swierniak M, Wojcicka A, Czetwertynska M, Stachlewska E, Maciag M, Wiechno W, Gornicka B, Bogdanska M, Koperski L, de la Chapelle A, Jazdzewski K.
    J Clin Endocrinol Metab; 2013 Aug 05; 98(8):E1401-9. PubMed ID: 23783103
    [Abstract] [Full Text] [Related]

  • 7. Thymosin beta 10 correlates with lymph node metastases of papillary thyroid carcinoma.
    Zhang XJ, Su YR, Liu D, Xu DB, Zeng MS, Chen WK.
    J Surg Res; 2014 Dec 05; 192(2):487-93. PubMed ID: 24974154
    [Abstract] [Full Text] [Related]

  • 8. Discriminatory miRNAs for the Management of Papillary Thyroid Carcinoma and Noninvasive Follicular Thyroid Neoplasms with Papillary-Like Nuclear Features.
    Jahanbani I, Al-Abdallah A, Ali RH, Al-Brahim N, Mojiminiyi O.
    Thyroid; 2018 Mar 05; 28(3):319-327. PubMed ID: 29378472
    [Abstract] [Full Text] [Related]

  • 9. BRAFV600E mutation, BRAF-activated long non-coding RNA and miR-9 expression in papillary thyroid carcinoma, and their association with clinicopathological features.
    Shi C, Cao J, Shi T, Liang M, Ding C, Lv Y, Zhang W, Li C, Gao W, Wu G, Man J.
    World J Surg Oncol; 2020 Jun 27; 18(1):145. PubMed ID: 32593310
    [Abstract] [Full Text] [Related]

  • 10. [Expression of microRNA-221 and IL-17 in papillary thyroid carcinoma and correlation with clinicopathologic features].
    Jiang XL, Zhang H, Chen YL, Peng L.
    Zhonghua Bing Li Xue Za Zhi; 2017 Mar 08; 46(3):160-165. PubMed ID: 28297755
    [Abstract] [Full Text] [Related]

  • 11. MicroRNA-146b-3p Promotes Cell Metastasis by Directly Targeting NF2 in Human Papillary Thyroid Cancer.
    Yu C, Zhang L, Luo D, Yan F, Liu J, Shao S, Zhao L, Jin T, Zhao J, Gao L.
    Thyroid; 2018 Dec 08; 28(12):1627-1641. PubMed ID: 30244634
    [Abstract] [Full Text] [Related]

  • 12. Circulating microRNA124-3p, microRNA9-3p and microRNA196b-5p may be potential signatures for differential diagnosis of thyroid nodules.
    Yu S, Liu X, Zhang Y, Li J, Chen S, Zheng H, Reng R, Zhang C, Chen J, Chen L.
    Oncotarget; 2016 Dec 20; 7(51):84165-84177. PubMed ID: 27705935
    [Abstract] [Full Text] [Related]

  • 13. MicroRNA-146b: A Novel Biomarker and Therapeutic Target for Human Papillary Thyroid Cancer.
    Chou CK, Liu RT, Kang HY.
    Int J Mol Sci; 2017 Mar 15; 18(3):. PubMed ID: 28294980
    [Abstract] [Full Text] [Related]

  • 14. Expressions of miRNAs in papillary thyroid carcinoma and their associations with the BRAFV600E mutation.
    Huang Y, Liao D, Pan L, Ye R, Li X, Wang S, Ye C, Chen L.
    Eur J Endocrinol; 2013 May 15; 168(5):675-81. PubMed ID: 23416953
    [Abstract] [Full Text] [Related]

  • 15. MicroRNA-451 as a prognostic marker for diagnosis and lymph node metastasis of papillary thyroid carcinoma.
    Zhang M, Wu W, Gao M, Fei Z.
    Cancer Biomark; 2017 Jul 04; 19(4):437-445. PubMed ID: 28582849
    [Abstract] [Full Text] [Related]

  • 16. Dicer expression and microRNA dysregulation associate with aggressive features in thyroid cancer.
    Erler P, Keutgen XM, Crowley MJ, Zetoune T, Kundel A, Kleiman D, Beninato T, Scognamiglio T, Elemento O, Zarnegar R, Fahey TJ.
    Surgery; 2014 Dec 04; 156(6):1342-50; discussion 1350. PubMed ID: 25456905
    [Abstract] [Full Text] [Related]

  • 17. BRAF mutation, selected miRNAs and genes expression in primary papillary thyroid carcinomas and local lymph node metastases.
    Kalfert D, Ludvikova M, Pesta M, Hakala T, Dostalova L, Grundmannova H, Windrichova J, Houfkova K, Knizkova T, Ludvik J, Polivka J, Kholova I.
    Pathol Res Pract; 2024 Jun 04; 258():155319. PubMed ID: 38696857
    [Abstract] [Full Text] [Related]

  • 18. MicroRNA Expression and Association with Clinicopathologic Features in Papillary Thyroid Cancer: A Systematic Review.
    Aragon Han P, Weng CH, Khawaja HT, Nagarajan N, Schneider EB, Umbricht CB, Witwer KW, Zeiger MA.
    Thyroid; 2015 Dec 04; 25(12):1322-9. PubMed ID: 26414548
    [Abstract] [Full Text] [Related]

  • 19. Associations of miR-146a and miR-146b expression and clinical characteristics in papillary thyroid carcinoma.
    Sun M, Fang S, Li W, Li C, Wang L, Wang F, Wang Y.
    Cancer Biomark; 2015 Dec 04; 15(1):33-40. PubMed ID: 25524940
    [Abstract] [Full Text] [Related]

  • 20. MicroRNAs miR-146-5p and let-7f as prognostic tools for aggressive papillary thyroid carcinoma: a case report.
    Geraldo MV, Fuziwara CS, Friguglieti CU, Costa RB, Kulcsar MA, Yamashita AS, Kimura ET.
    Arq Bras Endocrinol Metabol; 2012 Nov 04; 56(8):552-7. PubMed ID: 23295297
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 56.